MEDOVEX CORP (MDVX) financial statements (2021 and earlier)

Company profile

Business Address 201 E KENNEDY BLVD STE 700
TAMPA, FL 33602
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 472458931,570
Cash and cash equivalents 472458931,570
Receivables 146150 33
Inventory, net of allowances, customer advances and progress billings 131295 2
Inventory 131295 2
Prepaid expense 46205365170
Other undisclosed current assets  244  
Total current assets: 3711,1381,2581,775
Noncurrent Assets
Property, plant and equipment 30879825
Long-term investments and receivables   150 
Accounts and financing receivable, after allowance for credit loss   150 
Intangible assets, net (including goodwill)    6,456
Goodwill    6,456
Deposits noncurrent assets 3333
Other undisclosed noncurrent assets    3,274
Total noncurrent assets: 33902509,757
TOTAL ASSETS: 4041,2281,50811,532
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 1,575329755455
Accounts payable 751196226278
Accrued liabilities 21164460100
Employee-related liabilities 451   
Interest and dividends payable 162696977
Debt 6971321,096135
Due to related parties 9112  
Deferred revenue and credits1  
Other undisclosed current liabilities 37   
Total current liabilities: 2,4004751,851590
Noncurrent Liabilities
Long-term debt and lease obligation  39104919
Long-term debt, excluding current maturities  39104919
Other undisclosed noncurrent liabilities 0110
Total noncurrent liabilities: 040105919
Total liabilities: 2,4015151,9561,509
Stockholders' equity
Stockholders' equity attributable to parent, including: (1,997)713(448)10,023
Preferred stock  0  
Common stock 25211511
Additional paid in capital 35,81233,51025,89820,145
Accumulated deficit (37,834)(32,817)(26,361)(10,133)
Other undisclosed stockholders' equity attributable to parent 0   
Total stockholders' equity: (1,997)713(448)10,023
TOTAL LIABILITIES AND EQUITY: 4041,2281,50811,532

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 818207 33
Cost of revenue (503)(163) (25)
Cost of goods and services sold  (163) (25)
Other undisclosed gross profit  (0)  
Gross profit: 31545 8
Operating expenses (5,042)(6,105)(12,858)(6,476)
Operating loss: (4,727)(6,061)(12,858)(6,469)
Interest and debt expense (162)(395)(455)(54)
Loss from continuing operations: (4,889)(6,456)(13,313)(6,523)
Loss from discontinued operations  (1)(2,914) 
Net loss: (4,889)(6,457)(16,227)(6,523)
Other undisclosed net income (loss) attributable to parent (20)1  
Net loss attributable to parent: (4,909)(6,456)(16,227)(6,523)
Preferred stock dividends and other adjustments (58)   
Other undisclosed net loss available to common stockholders, basic (511)   
Net loss available to common stockholders, diluted: (5,478)(6,456)(16,227)(6,523)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (4,889)(6,457)(16,227)(6,523)
Comprehensive loss, net of tax, attributable to parent: (4,889)(6,457)(16,227)(6,523)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: